Atara Biotherapeutics Inc

Atara Biotherapeutics’ stock surges after a pivotal FDA decision on its viral‑therapy program, sparking investor interest and highlighting the company’s growth potential in biotech.

Atara Biotherapeutics is a biotech company dedicated to developing innovative therapies for severe and life-threatening diseases, with a focus on making a meaningful impact in the healthcare sector.